His clinical and research interests are focused on improving outcomes for people with neurodegenerative disorders, including accelerating early and accurate diagnoses, evaluating atypical presentations, leading population-based disease registries for longitudinal deep clinical phenotyping, digital and wet lab biomarker development/reverse translation, and delivery of innovative clinical trials.